Mann Lab

Radboud University Medical Center

Oost-Nederland (NL2) · Netherlands

ERC-funded
Rate this labNo reviews yet — be the first.

Research focus

ERC Consolidator Grant · 2022

Screening And Future Enhanced MRI

SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI. First SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for population screening (age 45-50). Early diagnosis of breast cancer in these women will lead to a large gain in DALY’s averted. I will initiate a prospective screening study inviting women to a one-time only abbreviated breast MRI at the age of 45. The primary outcome will be the cancer detection rate per 1000 women actually screened. This will validate abbreviated breast MRI as standalone screening technique. Psycho-social and risk information will be collected from…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.

Reviews

← All labs at Radboud University Medical Center